Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Insights, Forecast to 2034
Market Analysis and InsightsGlobal Contract Development and Manufacturing Organization (CDMO) Outsourcing Market
Global Contract Development and Manufacturing Organization (CDMO) Outsourcing market is expected to reach to US$ 90040 million in 2023, with a positive growth of %, compared with US$ 79390 million in 2022. Backed with the increasing demand from downstream industries, Contract Development and Manufacturing Organization (CDMO) Outsourcing industry is evaluated to reach US$ 159510 million in 2033. The CAGR will be 10.0% during 2023 to 2033.
The CDMO is an outsourcing contract established between a pharmaceutical company and a contract manufacturing business. It allows the partial or complete transfer of development and production of a product or a medical device. The contract manufacturers generally have a very wide range of services. The goal is to be able to provide global solutions to pharmaceutical companies, either on an ad hoc basis, or by offering a turnkey service of the product, including galenic and stability developments, marketing authorisation applications, purchases, production and regulatory affairs.
Report Covers
This report presents an overview of global Contract Development and Manufacturing Organization (CDMO) Outsourcing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Contract Development and Manufacturing Organization (CDMO) Outsourcing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Aenova Holding
Almac Group
Catalent
FAMAR Health Care Services
FAREVA
Lonza Group
Recipharm
Siegfried Holding
The Lubrizol
Thermo Fisher Scientific
Segment by Type
Small molecules
Biologics
API
Drug
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Contract Development and Manufacturing Organization (CDMO) Outsourcing introduction, etc. Contract Development and Manufacturing Organization (CDMO) Outsourcing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Contract Development and Manufacturing Organization (CDMO) Outsourcing
Chapter 13Methodology and Data Sources adopted by MRAResearch
Global Contract Development and Manufacturing Organization (CDMO) Outsourcing market is expected to reach to US$ 90040 million in 2023, with a positive growth of %, compared with US$ 79390 million in 2022. Backed with the increasing demand from downstream industries, Contract Development and Manufacturing Organization (CDMO) Outsourcing industry is evaluated to reach US$ 159510 million in 2033. The CAGR will be 10.0% during 2023 to 2033.
The CDMO is an outsourcing contract established between a pharmaceutical company and a contract manufacturing business. It allows the partial or complete transfer of development and production of a product or a medical device. The contract manufacturers generally have a very wide range of services. The goal is to be able to provide global solutions to pharmaceutical companies, either on an ad hoc basis, or by offering a turnkey service of the product, including galenic and stability developments, marketing authorisation applications, purchases, production and regulatory affairs.
Report Covers
This report presents an overview of global Contract Development and Manufacturing Organization (CDMO) Outsourcing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Contract Development and Manufacturing Organization (CDMO) Outsourcing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Aenova Holding
Almac Group
Catalent
FAMAR Health Care Services
FAREVA
Lonza Group
Recipharm
Siegfried Holding
The Lubrizol
Thermo Fisher Scientific
Segment by Type
Small molecules
Biologics
Segment by Application
API
Drug
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Contract Development and Manufacturing Organization (CDMO) Outsourcing introduction, etc. Contract Development and Manufacturing Organization (CDMO) Outsourcing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Contract Development and Manufacturing Organization (CDMO) Outsourcing
Chapter 13Methodology and Data Sources adopted by MRAResearch
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices